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1. Introduction
  The Emergency Centre is the part of the University Clinical 
Centre of Kosova and is the reference Emergency Centre 
for all cities of Kosovo. The center is visited annually by 40 
000 patients from which 8 000 are admitted to emergency for 
further treatment and analysis.
  There are many cases that end up that are not emergent 
but since they look for help the doctors ethics cannot let 
them untreated. One of the reasons for such high flux of 
patients is the lack of secondary medicine hospital in 
Prishtina capital of Kosovo. 
  If we focus only in cardiac arrest cases, these in 
Emergency Center in Kosovo are increasing with time. 
These cases in the bigger percentage end up with exitus 
including approximately 90% of prehospital cases and 60% 
of hospitalized cases. 
  The main objective is to assess the role of adrenaline and 
amiodarone use in cardiac arrest whether their use has 
helped to reduce of the percentage of death cases[1,3].
  This is a serious indicator that we have to carefully and 
with competence deal with these cases. The big percentage 
of cases that end up with exitus which is 90% is much 
higher than the official percentage in the USA or EU. This is 
one of the indicators that we in Kosovo need to work on to 
decrease it.
  Another issue is the use of the latest protocols of treatment 
and the availability of medicinal products in the right time 
(there is lack of availability for full list of essential list in 
Kosovo).
  And the third indicator is the maintenance of the survivals 
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after the cardiac arrest to increase their life expectancy 
years which is another indicator that in Kosovo is below the 
official statistics of USA and EU[1,5,8,9].
   Amiodarone may be considered for VF or pulseless VT 
unresponsive to CPR, defibrillation, and a vasopressor 
therapy (Class IIb, LOE B). An initial dose of 300 mg IV/IO 
can be followed by 1 limited experience with amiodarone 
given by this route. Cardiac arrest centres There is wide 
variation in dose of 150 mg IV/IO. Although anecdotally 
administered IO without known adverse effects, there is 
patient survival rates among hospitals caring for patients 
after resuscitation from cardiac arrest[1,3]. 
2. Materials and methods 
  The research it is done in Emergency Centre of Kosovo 
during 2010 and 2011. The main data were excluded from 
patient records and we have chosen 269 patients with cardiac 
arrest (only cases of cardiac arrest with cardiac origin). Also 
there has been done a comparison with cases presented in 
journals and other papers retrieved from databases.
3. Results 
  The total number of patients that are considered for this 
research were 269 in Figure 1. According to the gender there 
is a significant higher number of females with cardiac arrest 
Table 1 or their percentage shown in Figure 1.  
 
Figure 1. Structure of patients with cardiac arrest.
  Median age of patients was 56.7 years old (with SD依16.0 
years). The youngest patient was less than one year old and 
the oldest one was 92 years old.
  The median age of female patients was 55.2 while the 
youngest one was 20 years old and the oldest one was 
92. From the male patients the median age was 57.3, the 
youngest one was less than one and the oldest one was 87 
years old Table 2. 
  Another parameter analysed is the day of the week when 
the number of cases with cardiac arrest was higher. From the 
Table 3 we see that on Mondays with 32% of the cases their 
number is significantly higher than other days. Another day 
that the number is high is Friday with 24.5% of cases.
Table 2





n 83 186 269
Mesatarja 55.2 57.3 56.7
DS 14.6 16.6 16.0
Min 20.0   1.0   1.0
Max 92.0 87.0 92.0
T-test, P-value T=0.99, P>0.05
Table 3
Cardiac arrest cases according to the day of the week.
Day n %
Monday   86   32.0
Tuesday   25     9.3
Wednesday   34   12.6
Thursday   29   10.8
Friday   66   24.5
Saturday   26     9.7
Sunday   23     8.6
Total 269 100.0
  To all patients is given sodium chloride solution 0.9%. 
While to 245 patient or 91.1% is applied Adrenaline as a 
drug of choice of cases with caridac arrest. At 23.8% of cases 
is given Amiodarone, at 14.5% Atropine, at 4.1% NaHCO3 , at 
2.6% lidocaine and at 2.2% is given Dopamine (Figure 2).
 
Figure 2. Therapy applied to patients with cardiac arest.
   There is indirect evidence that regional cardiac systems 
of care improve outcome after STEMI.The implication from 
all these data is that specialist cardiac arrest centres and 
systems of care may be effective but direct evidence is 
awaited. When treating VF/VT cardiac arrest, adrenaline 1 
mg is given once chest have restarted after the third shock 
and then every 3-5 min (during alternate cycles of CPR). In 
the 2005 Guidelines, adrenaline was just before the third 
shock. This subtle change in the timing of administration 
is to separate the timing of drug delivery from attempted 
defibrillation. It is hoped that this will result in more 
efficient shock delivery and less interruption in chest 
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compressions. Amiodarone 300 mg is also given after the 
third shock[2,7,6].
4. Discussion
  There is no evidence that any antiarrhythmic drug given 
routinely during human cardiac arrest increases survival to 
hospital discharge. Amiodarone, however, has been shown 
to increase short-term survival to hospital admission We 
have concluded that if the therapy is given within 10 min 
after cardiac arrest the percentage of survival could much 
higher. We did not have any survived which have came ten 
minutes after the cardiac arrest in the center. If we focus only 
in cardiac arrest cases, these in Emergency Center in Kosovo 
are increasing with time. These cases in the bigger percentage 
end up with exitus including approximately 90% of prehospital 
cases and 60% of hospitalized cases. The use of adrenaline 
every 3-5 min in a dose 1mg IV/IO shows good results 
while the amiodarone cases had no significantly increase in 
the overall percentage of survival[1]. Although anecdotally 
administered IO without known adverse effects, there is limited 
experience with amiodarone given by this route. On the basis 
of expert consensus, if VF/VT persists, give amiodarone 300 mg 
by bolus injection (flushed with 20 mL of 0.9% sodium chloride 
or 5% dextrose)177 after the third shock. A further dose of 150 
mg may be given for recurrent or refractory VF/VT, followed 
by an infusion of 900 mg over 24 h. Lidocaine 1 mg/kg may 
be used as an alternative if amiodarone is not available, but 
do not give lidocaine if amiodarone has been given already.
The research shows that if the patient is able to be sent to 
the center within 10 min from the cardiac arrest the chance 
of survival is higher[3,11-13]. The recommendation from this 
research is that the relevant authorities has to take decisions 
to make proper trainings to the medical staff working not only 
in emergency centre but as well other family centers for the 
treatment of cardiac arrest with a proper dosage of adrenaline 
and other drugs needed, which would increase the percentage 
of survival. Three initial stacked shocks are given only in very 
specific circumstances-in the cardiac catheter laboratory, in 
patients who have just had cardiac surgery, and those who 
have a witnessed monitored arrest and are already connected 
to a manual defibrillator. These 3 initial stacked shocks should 
be considered as the first shock in the ALS algorithm and both 
adrenaline and amiodarone should be given after a further 2 
defibrillation attempts (i.e. delayed until after the fifth shock)
[1,3,13].
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